1420 companies · 1441 sector slots · 20 sectors · 29 below Rs1000cr and not scanned · long-term lens
Trend Spotlight
BBTC's Franchise Risk is re-rated down after a company-secretary resignation and a still-contested Rs4,655cr lease dispute surface alongside otherwise strong results.
Bombay Burmah Trading Corp's Compliance Officer resigned in July for personal reasons, and the company is separately contesting a Rs4,655cr lease-rent claim on its Singampatti tea estate that remains unresolved -- a material contingent liability that wasn't part of the prior clean Franchise Risk read. Q1 results were otherwise solid, with revenue and profit both up YoY, so this doesn't touch the BUY call's fundamentals, but it is the kind of governance-adjacent overhang a long-term holder should keep tracking until the dispute resolves.
No confirmed GIFT Nifty or Asia-cues read for today's open; Wednesday's RBI hike is still the operative backdrop.
Search did not turn up a dated GIFT Nifty or Asian-markets wrap for today -- the freshest confirmed index levels are an October 5 close (Sensex ~71,910, Nifty ~22,422) and September 30 (Sensex 72,480, Nifty 22,620), both too stale to use as a gap signal. Crude and USD/INR levels are similarly unconfirmed from today's search, though a Kalshi market implies Brent near/above $100, consistent with the rupee weakness and high crude the RBI itself cited on Oct 7. The Fed's next decision isn't until Oct 27-28; prediction-market sentiment has swung toward a hold (82% per an Oct 2 snapshot, from 66% hike odds in late September), a dovish-leaning read that is now over a week stale.
Source: NSE event calendar, filtered to the 1420 tracked names.
Market Overview
Index
Close
Points
Change
P/E
P/B
Nifty 50
22,520.45
▲ +288.65
▲ +1.30%
19.27
2.77
Nifty Next 50
68,166.70
▲ +552.20
▲ +0.82%
17.86
3.27
Nifty 500
21,866.65
▲ +250.50
▲ +1.16%
21.56
3.06
Nifty Bank
55,256.65
▲ +741.60
▲ +1.36%
13.10
1.66
NIFTY Midcap 100
58,787.30
▲ +904.80
▲ +1.56%
27.73
3.74
▲ 1649 advancing■ 30 unchanged▼ 993 decliningof 2672 equities, vs the 2026-10-08 close
Cash market, ₹ crore
FII / FPI net
▼ -3,568.90
bought 10,374 · sold 13,943
DII net
▲ +4,743.26
bought 15,627 · sold 10,883
FII / FPI
DII
Source: NSE ind_close_all_20261009
(levels, index P/E and P/B) and the full-market bhavcopy (breadth).
Index P/E from NSE's official daily index file.
Since We Flagged
The desk's track record — every call it has published, scored over the
stretch it actually stood: from the close on the day it was made (restated for any
split or bonus) to the day the desk changed it, the name left coverage, or today.
Each is set against Nifty 500 over the same window. A BUY should beat it; an AVOID
should lag it.
3631 calls scored since Wed, 5 Aug 2026: 1385 standing, 1648 closed when the desk changed the call, 598 closed when the name left coverage (at its last published close). 2017 of them are the call a name was given on entering coverage, not one the desk changed to. 1373 more standing calls with history are not shown — this table is the 12 that have moved most against Nifty 500 since they were made. 29 calls published this session are not scored yet — no session to move in. 23 have no cached close at one end of their window and are not scored. 9 entry prices restated for a split or bonus inside the window (marked adj.).
BBTC's Company Secretary resigns as it contests a Rs4,655cr lease-rent claim on its Singampatti tea estate FMCG
Bombay Burmah Trading Corp's Company Secretary and Compliance Officer resigned in July 2026 citing personal reasons, and the company is separately contesting a Rs4,655cr lease-rent claim on its Singampatti tea estate that remains unresolved. Q1 results showed revenue and profit both rising, so there's no guidance cut, but the unresolved contingent liability is material enough to move BBTC's Franchise Risk read down from a prior clean 5/5.
Zensar's TMT and healthcare weakness confirmed in hard numbers, but framed as insourcing/consolidation, not 'client exits' Information Technology
Zensar's Q1 FY27 data shows TMT revenue down 9.1% QoQ (-28.0% YoY constant currency) and healthcare/life-sciences down 3.8% QoQ (-8.7% YoY), confirming real sequential weakness in the two verticals the open claim flagged. A brokerage attributes this to the top client insourcing work and vendor-consolidation hits to a couple of accounts, not outright client exits as previously framed -- the underlying concern stands, but the mechanism is now better specified. Q3 FY27 results, the claim's stated falsifier, haven't reported yet.
Shukra Pharmaceuticals' Q1 profit jumps, but sources disagree sharply on how many unrelated subsidiaries it now runs Pharmaceuticals
Shukra posted Q1 FY27 net profit of roughly Rs12cr against about Rs1cr a year earlier, on revenue growth sources peg between 270% and 336% YoY -- a standout beat. But one filing summary counts four subsidiaries (medtech, robotics, woundcare, diabetes tech) while another FY26 annual-report-based source counts nine, including defence and AI -- a direct conflict on the scale of diversification central to the open governance-risk claim. FY26 free cash flow was negative, consistent with the claim's capital-intensity concern; no FY27 capex breakdown exists yet to judge execution.
NALCO posts its best-ever FY26 and signs a 1,080MW captive-power JV to feed smelter expansion Metals & Mining
National Aluminium reported record FY26 net profit (Rs5,816cr, +9.22%) and record revenue (Rs17,843cr) at its August 31 AGM, alongside a new 50:50 joint venture with NLC India for a 1,080MW captive thermal plant to power planned smelter capacity growth. The company is also exploring rare-earth/critical-mineral recovery from bauxite residue. Nothing found here would falsify the existing BUY call; it supports the growth-outlook read.
Entry score is 40% cheap-vs-history + 25% quality trend + 20% news catalyst + 15% technicals, for the 4 sectors with a researched catalyst. The other 16 show —: no catalyst was researched for them, so their score renormalises over the remaining three inputs rather than assuming a neutral headline. ≥62 accumulate · 45–61 watch · <45 avoid.
Source: data/verdicts.json × NSE sector index closes.
Stocks to Watch
Split evenly across large/mid/small/micro cap so this list isn't one
tier's picks — new calls first, then the highest long-term composites within each.
Micro-cap names are boxed and flagged Highly Volatile — worth
watching, not a call to buy — since their price swings run about twice every other
tier's. Each card shows the figures that selected it — open the desk for the full
six-lens panel.